Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury (APT-TBI-01)
Sponsor: United States Department of Defense
This PHASE2 trial investigates Traumatic Brain Injury and is currently ongoing. United States Department of Defense leads this study, which shows 13 recorded versions since 2024 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Enrolling By Invitation PHASE2
-
Nov 2025 — Jan 2026 [monthly]
Enrolling By Invitation PHASE2
-
Oct 2025 — Nov 2025 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Enrolling By Invitation PHASE2
-
Jul 2025 — Sep 2025 [monthly]
Enrolling By Invitation PHASE2
▶ Show 8 earlier versions
-
Apr 2025 — Jul 2025 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2024 — Apr 2025 [monthly]
Enrolling By Invitation PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE2
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2023 — Jun 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE2
-
May 2023 — Jul 2023 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- United States Department of Defense
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .